Key result
Continuous in-line blood gas monitoring cuts CPB pCO2 protocol deviations by an absolute ~18%.
Why the study?
Does continuous blood gas monitoring improve blood gas management in patients undergoing cardiopulmonary bypass?
RCT (n=100)
Single-blind (surgical, intensive care, and postoperative management teams blinded; perfusionist blinded to CDI500 in control group only)
Computerized random number generator
No
Does continuous blood gas monitoring improve blood gas management in patients undergoing cardiopulmonary bypass?
Continuous blood gas monitoring during cardiopulmonary bypass significantly improves adherence to institutional blood gas management protocols compared to intermittent monitoring.
Answers are grounded in this paper and cite their sources.
Continuous monitoring may improve pCO2 adherence during CPB; this RCT confirms superiority over intermittent sampling.
The CDI™500 (Terumo Cardiovascular Systems, Ann Arbor, MI) is an in-line blood gas monitoring device that has been used in clinical practice for over a decade. Few randomized studies have evaluated the value of this device with respect to improved perfusion management. We routinely use automated continuous quality indicator programs to assess perfusion management. The aim of this study is to investigate in a prospective randomized trial the role of in-line blood gas monitoring in the improvement of blood gas management during cardiopulmonary bypass (CPB) utilizing continuous quality indicators. Patients were randomized into two groups (Control, CDI). Patients in the Control group received our standard CPB blood gas management, with intermittent blood gas results. Continuous blood gas measurements from the CDI™500 were recorded at 20-second intervals, with the perfusionist blinded to these measurements. Patients in the CDI group received standard CPB blood gas management, in addition to continuous blood gas measurements visible on the CDI™500, the alarm system activated, and the data recorded. Perfusion management for all cases was guided by institutional protocols. One hundred patients (50 in each group) were included in the study. No significant difference existed between the groups on demographic, surgical, or clinical outcomes. Blood gas levels of patients in the CDI group were able to be maintained in accordance to protocol a greater percentage of the time, e.g., pCO2management was 2% versus 20% (p= .008); this was most notable for differences between the Control and the CDI group for pCO2> 45 mmHg (p= .003). Practice variation determined via statistical control charts improved for both pH and pCO2, represented by a decrease in the variation associated with practice. Continuous blood gas monitoring with the CDI™500 results in significantly improved blood gas management as determined by adherence to institutional protocols.
No takes yet. Share an insight, caveat, or question.
Ottens et al. (2010) conducted an RCT in Cardiac surgery requiring cardiopulmonary bypass (n=100). Continuous in-line blood gas monitoring (CDI 500) vs. Standard CPB blood gas management with intermittent laboratory blood gas sampling (perfusionist blinded to CDI 500) was evaluated on Quality control protocol deviations in pCO2 management (<35 or >45 mmHg) (p=0.008). Continuous in-line blood gas monitoring with the CDI 500 reduced pCO2 protocol deviations from 20% to 2% of cases compared to intermittent sampling during cardiopulmonary bypass.
Synapse has enriched 10 related papers. Consider them for comparative context: